Response to omalizumab using patient enrichment criteria from trials of novel biologics in asthma.
Thomas B CasaleB E ChippsK RosénB TrzaskomaT HaselkornT A OmachiS GreenbergN A HananiaPublished in: Allergy (2017)
In patients with allergic asthma, baseline blood eosinophil levels and/or clinical markers of asthma severity predict response to omalizumab.